Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.
|Medicine name||phenazone and lidocaine (Otigo®)|
|Formulation||40 mg/10 mg per g ear drops|
Local symptomatic treatment and relief of pain in the following diseases of the middle ear without tympanic perforation: acute, congestive otitis media; otitis in influenza, the so called viral bullous otitis; barotraumatic otitis
|Company||Renascience Pharma Ltd|
|BNF chapter||Ear, nose & oropharynx|
|Date of issue||11/02/2021|